ATE6126T1 - 99m tc markierte diagnostische zusammensetzungen und verfahren zu ihrer herstellung. - Google Patents

99m tc markierte diagnostische zusammensetzungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE6126T1
ATE6126T1 AT81102973T AT81102973T ATE6126T1 AT E6126 T1 ATE6126 T1 AT E6126T1 AT 81102973 T AT81102973 T AT 81102973T AT 81102973 T AT81102973 T AT 81102973T AT E6126 T1 ATE6126 T1 AT E6126T1
Authority
AT
Austria
Prior art keywords
manufacture
processes
diagnostic compositions
labeled diagnostic
labeled
Prior art date
Application number
AT81102973T
Other languages
English (en)
Inventor
Edgar Haber
Ban An Khaw
Original Assignee
The Massachusetts General Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Massachusetts General Hospital filed Critical The Massachusetts General Hospital
Application granted granted Critical
Publication of ATE6126T1 publication Critical patent/ATE6126T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Optics & Photonics (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT81102973T 1980-04-17 1981-04-16 99m tc markierte diagnostische zusammensetzungen und verfahren zu ihrer herstellung. ATE6126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/141,053 US4421735A (en) 1980-04-17 1980-04-17 Radiolabeled diagnostic compositions and method for making the same
EP81102973A EP0038546B1 (de) 1980-04-17 1981-04-16 99m Tc markierte diagnostische Zusammensetzungen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE6126T1 true ATE6126T1 (de) 1984-02-15

Family

ID=22493955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81102973T ATE6126T1 (de) 1980-04-17 1981-04-16 99m tc markierte diagnostische zusammensetzungen und verfahren zu ihrer herstellung.

Country Status (5)

Country Link
US (1) US4421735A (de)
EP (1) EP0038546B1 (de)
JP (1) JPS56164123A (de)
AT (1) ATE6126T1 (de)
DE (1) DE3162157D1 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
GB2122641B (en) * 1982-06-07 1986-08-06 Otto A Gansow Metal chelate conjugated monoclonal antibodies where in the metal is an emitter
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
CA1223831A (en) * 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US4479930A (en) * 1982-07-26 1984-10-30 Trustees Of The University Of Massachusetts Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
US4485086A (en) * 1983-04-11 1984-11-27 Wong Dennis W Radiolabeled tumor imaging agent and method of preparation
US4851515A (en) * 1983-12-29 1989-07-25 The Commonwealth Of Australia Preparation of 99m Tc radiopharmaceuticals
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
US4652440A (en) * 1984-05-03 1987-03-24 Paik Chang H Method of stably radiolabeling antibodies with technetium and rhenium
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
EP0170031A1 (de) * 1984-07-04 1986-02-05 Gesellschaft zur Förderung der industrieorientierten Forschung an den Schweizerischen Hochschulen und weiteren Institutionen Radioaktives Diagnosemittel zum Nachweisen einer venösen Thrombose
US4937067A (en) * 1984-12-13 1990-06-26 Massachusetts Institute Of Technology Method and means for detection of adrenal metabolic activity
US4897255A (en) * 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5556982A (en) * 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5045303A (en) * 1985-05-17 1991-09-03 Neorx Corporation Radiohalogenated small molecules for protein labeling
CA1333264C (en) * 1985-06-07 1994-11-29 Suresh C. Srivastava Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi
US5011913A (en) * 1985-06-28 1991-04-30 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
DE3670571D1 (de) * 1985-07-05 1990-05-31 Causse Jean Etienne Verfahren zur reduktion von pertechnetat.
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
WO1988002635A1 (en) * 1986-10-17 1988-04-21 Cytogen Corporation Method for preparation of protein-chelator-metal ion compositions suitable for injection
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US5202451A (en) * 1988-02-17 1993-04-13 Neorx Corporation Anchimeric radiometal chelating compounds
USH735H (en) 1988-03-30 1990-02-06 The United States Of America As Represented By The United States Department Of Energy Lead-203 as a label for radioimaging
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5059541A (en) * 1988-04-29 1991-10-22 Neorx Corporation Minimal derivatization of proteins
US4917878A (en) * 1988-05-02 1990-04-17 Thomas Jefferson University Novel use of a radiolabelled antibody against stage specific embryonic antigen for the detection of occult abscesses in mammals
US5066479A (en) * 1988-05-31 1991-11-19 The Regents Of The Univ. Of California Metallacarborane chelates
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5208007A (en) * 1988-11-22 1993-05-04 Board Of Regents Of The University Of Oklahoma Isotopic tracer composition and method for making and using same
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
ES2125854T3 (es) * 1989-08-09 1999-03-16 Rhomed Inc Radiomarcado directo de anticuerpos y otras proteinas con tecnetio o renio.
US5346687A (en) * 1989-08-09 1994-09-13 Rhomed Incorporated Direct radiolabeling of antibody against stage specific embryonic antigen for diagnostic imaging
US5078985A (en) * 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
GB9000705D0 (en) * 1990-01-12 1990-03-14 Royal Postgrad Med School Improvements in or relating to radiotherapeutic agents
CA2079206A1 (en) * 1990-03-26 1991-09-27 Martin W. Brechbiel Fonctionalized complexand
US5080883A (en) * 1990-05-11 1992-01-14 Mallinckrodt, Inc. 99 mtcn3s-conjugated anti-bibrin monoclonal antibody as an in vivo diagnostic agent for imaging
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
JPH07149668A (ja) * 1993-11-30 1995-06-13 Kanegafuchi Chem Ind Co Ltd アミロイド沈着検出用物質
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US5804158A (en) * 1995-05-31 1998-09-08 Resolution Pharmaceuticals Inc. Sequestered imaging agents
AU741338B2 (en) * 1996-09-20 2001-11-29 Bristol-Myers Squibb Company Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin
US6080384A (en) * 1997-03-25 2000-06-27 American Biogenetic Sciences, Inc. Methods for radionuclide-labeling of biomolecules and kits utilizing the same
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7875162B2 (en) * 2004-03-26 2011-01-25 Board Of Regents, University Of Houston Monitored separation device
US8309306B2 (en) * 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
EP2204377A1 (de) * 2008-12-30 2010-07-07 Commissariat à l'énergie atomique et aux énergies alternatives Cysteinfreie, Technetium- oder Rhenium-chelatisierende Peptidsequenzen und deren Verwendung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725295A (en) * 1971-07-20 1973-04-03 Atomic Energy Commission Technetium labeling
FR2281134A1 (fr) * 1974-08-06 1976-03-05 Commissariat Energie Atomique Procede de marquage au 99m technetium
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
US4022877A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Radioactive labeled orgotein
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
CH630261A5 (de) * 1977-09-08 1982-06-15 Solco Basel Ag Verfahren und ampulle zur herstellung von radiopharmazeutika.
US4323546A (en) * 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4272503A (en) * 1978-05-25 1981-06-09 New England Nuclear Corporation Reductant composition for technetium-99m and method for making technetium-99m labelled ligands

Also Published As

Publication number Publication date
EP0038546A3 (en) 1982-02-24
EP0038546A2 (de) 1981-10-28
JPS56164123A (en) 1981-12-17
EP0038546B1 (de) 1984-02-08
DE3162157D1 (en) 1984-03-15
US4421735A (en) 1983-12-20

Similar Documents

Publication Publication Date Title
ATE6126T1 (de) 99m tc markierte diagnostische zusammensetzungen und verfahren zu ihrer herstellung.
Princiotto et al. Difference between the two iron-binding sites of transferrin
ATE58297T1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
ATE247985T1 (de) Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden
AU598183B2 (en) Coupling agents for radiolabeled antibody fragments
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
PT630265E (pt) Peptidos marcados com tecnecio 99m para processamento de imagem de inflamacao
DK0684843T3 (da) Technetium-99m-mærkede peptider til diagnostisk billeddannelse af inflammation
ATE54417T1 (de) Radioaktiv markierte antikoerperstuecke.
ATE296312T1 (de) Metalkomplexbildner
FI955319A0 (fi) 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina
PT762901E (pt) Peptidos marcados com tecnecio-99m para imagiologia.
ATE340594T1 (de) Somatostatin bindende peptide-metallchelat konjugate
DK0702570T3 (da) Technetium-99m-mærkede peptider til afbildning af inflammation
EP0173648A3 (de) Monoklonale Antikörper gegen Glykokonjugate, Verfahren zu ihrer Herstellung und Verwendungen
DE69529988D1 (de) Technetium-99m markierte bildformungsmittel
SE8002831L (sv) Oxitetracyklinberedningar
ATE128035T1 (de) Chelatierungsmittel zur bindung von metallionen zu proteinen.
NO307566B1 (no) Tris(isonitril)-kobber(I)-sulfat-komplekser, fremstilling derav, fremgangsmåte for fremstilling av et koordinasjonskompleks samt steril, ikke-pyrogen kit
ATE15109T1 (de) Verfahren zur herstellung einer chromogenen reaktionsmischung zur bestimmung der eisenkonzentration und -bindungskapazitaet von serum sowie die dabei erhaltene chromogene reaktionsmischung.
IT8447751A0 (it) Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
CH613177A5 (en) Process for labelling proteins using technetium
EP0289187A3 (de) Vinyl-substituierte Radiohalogen-Konjugate zur Markierung von Proteinen
ATE3752T1 (de) Technetium-99m-markierte acetanilidoiminodiacetate zur leberfunktionsdiagnostik und verfahren zu ihrer herstellung.
Rasched et al. Specific modification of a single cysteine residue in both bovine liver glutamate dehydrogenase and yeast glyceraldehyde-3-phosphate dehydrogenase Difference in the mode of midification by pyrene maleimide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee